Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
lumacaftor (VX-809)
print preview
bookmark
share with colleague
General Information
Company
Vertex Pharmaceuticals Inc.
Description
Small molecule cystic fibrosis transmembrane conductance regulator (CFTR) corrector
Molecular Target
Cystic fibrosis transmembrane conductance regulator (CFTR)
Mechanism of Action
CFTR stabilizer
Latest Stage of Development
Phase II
Indication
Cystic fibrosis (CF)
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information